2024

1. Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry

   The Journal of rheumatology, Vol. 51, Núm. 9, pp. 877-883